CLDX
Celldex Therapeutics Inc
NASDAQ · Biotechnology
$23.76
+1.18 (+5.23%)
Open$23.15
Previous Close$22.58
Day High$23.98
Day Low$22.33
52W High$30.50
52W Low$14.40
Volume—
Avg Volume676.4K
Market Cap1.58B
P/E Ratio—
EPS$-3.38
SectorBiotechnology
Analyst Ratings
Strong Buy
22 analysts
Price Target
+119.2% upside
Current
$23.76
$23.76
Target
$52.08
$52.08
$39.61
$52.08 avg
$81.09
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 7.24M | 6.31M | 588.88M |
| Net Income | -162,900,874 | -127,798,802 | -4,307,781 |
| Profit Margin | -2,248.8% | -2,136.3% | -0.7% |
| EBITDA | -198,026,064 | -163,986,018 | -9,082,544 |
| Free Cash Flow | — | — | -4,299,158 |
| Rev Growth | +14.7% | +14.7% | -8.7% |
| Debt/Equity | — | — | 0.92 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |